47,50 €
4,51 % heute
L&S, 16. Juli, 21:38 Uhr
ISIN
CH0334081137
Symbol
CRSP
Berichte
Sektor
Industrie

CRISPR Therapeutics AG Aktie News

Neutral
Seeking Alpha
2 Tage alt
Curing disease, as opposed to just masking symptoms, is a big deal. CRISPR Therapeutics aims to cure by editing problem genes. So CRSP is the future of medicine! This approach can be too futuristic for many tastes. That, plus questions about CRSP's ability to scale production and make treatments affordable, have been like a cloud over the stock. But in June, CRSP picked up some big-time express...
Positiv
The Motley Fool
8 Tage alt
When picking new stocks for your portfolio, your best bet is looking for companies that you can hold forever. It may take that long for an idea or a business premise to fully pay off!
Neutral
The Motley Fool
13 Tage alt
There are many promising corporations that investors can buy on a dip due to recent market volatility or company-specific issues that predate this year. Take, for instance, CRISPR Therapeutics (CRSP 6.43%) and Viking Therapeutics (VKTX 3.94%), two mid-cap biotech companies that have lagged broader equities over the trailing-12-month period.
Positiv
The Motley Fool
14 Tage alt
July kicks off the latter half of 2025, and the first six months of this year have been eventful, to say the least.
Neutral
GlobeNewsWire
20 Tage alt
-New Phase 1 clinical data for CTX310™ continues to demonstrate dose-dependent reductions in triglycerides (TG) and low-density lipoprotein (LDL), with peak reduction of up to 82% in TG and up to 86% in LDL, with a well-tolerated safety profile-
Positiv
The Motley Fool
22 Tage alt
Is it time to reload your portfolio with some new picks? That's easier said than done right now.
Positiv
The Motley Fool
25 Tage alt
If you're looking to add growth to your portfolio, biotech stocks can be a great choice. Exciting research is happening in these companies' labs, and in some cases, game-changing treatment candidates are approaching important milestones or even going over the finish line.
Negativ
Investors Business Daily
26 Tage alt
The latest shake-up at the FDA forced out the top two officials in charge of reviewing cell and gene therapies, analysts said.

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen